Allergan plc (AGN)
Symbol Info
Listed Symbol AGN
Name Allergan plc
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $15,787,400,000
Latest Fiscal EPS $-15.25
Price Info
21 Day Moving Average $159.5847
21 Day EMA $158.594920
50 Day Moving Average $151.9496
50 Day EMA $154.169110
200 Day EMA $151.350420
200 Day Moving Average 146.359150
52 Week High $197.00
52 Week Low $114.27
52 Week Change $-12.402400
Alpha -0.011493
Beta 1.6014
Standard Deviation 0.096872
R2 0.328996
Periods 60
Share Information
10 Day Average Volume 4,373,038
20 Day Average Volume 4,822,415
30 Day Average Volume 4,817,021
50 Day Average Volume 5,468,817
Outstanding Shares 328,032,715
Float Shares 325,823,392
Percent Float 99.33%
Short Interest 5,926,864
Short Percent Float 1.80%
Short Interest Ratio 1.18
Short Date 2019-07-31
Holders
Institutions 1,883
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 18,691,412
Institute Holdings Percent -
Institute Sold Previous 3 Months 46,352,041
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 2,209,323
Price Change
7 Day Price Change $-0.8499451
7 Day Percent Change -0.53%
21 Day Price Change $-1.9846649
21 Day Percent Change -1.24%
30 Day Price Change $-5.249481
30 Day Percent Change -3.21%
Month To Date Price Change $-1.5069
Month To Date Percent -0.94%
90 Day Price Change $18.858383
90 Day Percent Change 13.53%
Quarter To Date $-8.4048
Quarter To Date Percent -5.04%
180 Day Price Change $20.554780
180 Day Percent Change 14.93%
200 Day Price Change $1.957245
200 Day Percent Change 1.25%
Year To Date $26.609130
Year To Date Percent 20.21%
Profile
Description Allergan is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. In 2016, Allergan sold its generics and distribution segments to Teva.
Details
Issue Type CS
Market Cap $51,911,177,149
Sec Type EQS
Auditor PricewaterhouseCoopers LLP
Total Shares Outstanding 328,032,715
CEO Brenton L. Saunders
Employees 16,900
Last Audit UE
Classification
CIK 0001578845
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address Clonshaugh Business and Technology Park
Coolock
Dublin, D17E400
Website http://www.allergan.com
Facisimile
Telephone +353 8622617000
Email investorrelations@allergan.com
Key Ratios
Profitability
EBIT Margin -54.3
EBITDA Margin -15.1
Pre-Tax Profit Margin -35.4
Profit Margin Cont -54.18
Gross Margin 85.10
Profit Margin TOT -54.18
Income Statements
Revenue $15,678,300,000
Revenue Per Share $47.7949
Revenue 3 Years $0.80
Revenue 5 Years $4.85
Valuation Measures
PE Ratio -
Enterprise Value $72,552,434,663
Price To Sales 3.311021
Price To Free Cash 12.300000
PE High Last 5 Years -
Price To Book 0.9
Price To Cash Flow 9.3
PE Low Last 5 Years -
Price To Tangible Book -2.2
Financial Strength
Total Debt To Equity 0.4
Int Coverage -10.3
Current Ratio 1.0
Leverage Ratio 1.6
Quick Ratio 0.6
Long Term Debt To Capital 0.25
Assets
Receivables Turnover 2.2
Invoice Turnover 2.20
Assets Turnover 0.10
Management Effectiveness
Return Assets -8.32
Return On Equity -12.99
Return On Capital -8.69
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date 2019-08-12 00:00:00.0
Dividend Rate $2.96
Dividend Yield 1.87%
Payment Type Cash


Your Recent History
NYSE
AGN
Allergan
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.